In vitro studies with tumor cells and organoids revealed that Fusobacterium nucleatum exhibited a higher invasive ability in KRAS G12D mutant tumor cells than in KRAS G13D or wild‐type cells. The gene discussed is KRAS; the disease is neoplasm.